These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18537552)

  • 1. Skeletal muscle in cancer cachexia: the ideal target of drug therapy.
    Bossola M; Pacelli F; Tortorelli A; Rosa F; Doglietto GB
    Curr Cancer Drug Targets; 2008 Jun; 8(4):285-98. PubMed ID: 18537552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel treatments for cancer cachexia.
    Bossola M; Pacelli F; Doglietto GB
    Expert Opin Investig Drugs; 2007 Aug; 16(8):1241-53. PubMed ID: 17685872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer cachexia: it's time for more clinical trials.
    Bossola M; Pacelli F; Tortorelli A; Doglietto GB
    Ann Surg Oncol; 2007 Feb; 14(2):276-85. PubMed ID: 17094025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waste management - cytokines, growth factors and cachexia.
    Saini A; Al-Shanti N; Stewart CE
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):475-86. PubMed ID: 17118696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies.
    Martin A; Gallot YS; Freyssenet D
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1150-1167. PubMed ID: 36864755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle regeneration in cancer cachexia.
    Bossola M; Marzetti E; Rosa F; Pacelli F
    Clin Exp Pharmacol Physiol; 2016 May; 43(5):522-7. PubMed ID: 26857538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of cancer cachexia: new insights into an old problem.
    Muscaritoli M; Bossola M; Aversa Z; Bellantone R; Rossi Fanelli F
    Eur J Cancer; 2006 Jan; 42(1):31-41. PubMed ID: 16314085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic and local mechanisms leading to cachexia in cancer].
    Grabiec K; Burchert M; Milewska M; Błaszczyk M; Grzelkowska-Kowalczyk K
    Postepy Hig Med Dosw (Online); 2013 Dec; 67():1397-409. PubMed ID: 24493689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on emerging drugs for cancer cachexia.
    Murphy KT; Lynch GS
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):619-32. PubMed ID: 19860537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer cachexia.
    Tisdale MJ
    Langenbecks Arch Surg; 2004 Aug; 389(4):299-305. PubMed ID: 15168125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia.
    Melstrom LG; Melstrom KA; Ding XZ; Adrian TE
    Histol Histopathol; 2007 Jul; 22(7):805-14. PubMed ID: 17455154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the beta
    Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
    Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
    Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E
    J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediators of cachexia in cancer patients.
    Argilés JM; López-Soriano FJ; Busquets S
    Nutrition; 2019 Oct; 66():11-15. PubMed ID: 31177056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle metabolism and exercise capacity in cachexia.
    Adams V; Anker SD; Schuler G
    Curr Pharm Des; 2011 Dec; 17(35):3838-45. PubMed ID: 21933139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.
    Miyamoto Y; Hanna DL; Zhang W; Baba H; Lenz HJ
    Clin Cancer Res; 2016 Aug; 22(16):3999-4004. PubMed ID: 27340276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer cachexia pathophysiology and translational aspect of herbal medicine.
    Suzuki H; Asakawa A; Amitani H; Fujitsuka N; Nakamura N; Inui A
    Jpn J Clin Oncol; 2013 Jul; 43(7):695-705. PubMed ID: 23737606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials).
    Crawford J; Prado CM; Johnston MA; Gralla RJ; Taylor RP; Hancock ML; Dalton JT
    Curr Oncol Rep; 2016 Jun; 18(6):37. PubMed ID: 27138015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between muscle mass and function in cancer cachexia: smoke and mirrors?
    Ramage MI; Skipworth RJE
    Curr Opin Support Palliat Care; 2018 Dec; 12(4):439-444. PubMed ID: 30138131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia.
    Murphy KT; Chee A; Trieu J; Naim T; Lynch GS
    Int J Cancer; 2013 Sep; 133(5):1234-46. PubMed ID: 23436228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.